Skip to main content
. 2019 Dec 15;105(5):e2050–e2060. doi: 10.1210/clinem/dgz262

Table 1.

Participant Characteristics

Placebo (n = 86) TE + IMP (n = 86)
Demographic Information
Age, y (SD) 51.0 (3.2) 51.0 (3.0)
Race, No. (%)
 Caucasian 60/86 (70) 70/86 (81)
 African American 20/86 (23) 13/86 (15)
 Other 6/86 (7) 3/86 (4)
Educationa, mean (SD) 7.0 (1.1) 6.8 (1.1)
Incomeb, mean (SD) 9.0 (3.1) 8.7 (3.3)
Reproductive Stage, No. (%)
 Early Peri 18/86 (21) 18/86 (21)
 Late Peri 48/86 (56) 51/86 (59)
 Early Post 20/86 (23) 17/86 (20)
Plasma estradiol, pg/mL 90.1 (55.2) 104.7 (102.2)
Current smoker, No. (%) 6/86 (7) 4/86 (5)
Hot flash bother (SD; 0 = not at all; 3 = extremely) 1.1 (0.9) 1.0 (0.9)
Night sweat bother (SD; 0 = not at all; 3 = extremely) 1.1 (0.9) 0.9 (1.0)
Baseline Arterial Disease Risk Factors
Resting SBP (mmHg) 112.0 (11.9) 112.5 (11.3)
Resting DBP (mmHg) 70.7 (7.4) 70.1 (8.3)
BMI (kg/m2) 25.8 (3.7) 25.5 (3.6)
Waist circumference (cm) 88.4 (13.7) 87.2 (13.8)
LDL cholesterol (mg/dL) 115.4 (3.2) 119.9 (29.7)
HDL cholesterol (mg/dL) 70.0 (1.8) 67.4 (16.4)
Fasting insulin (mIU/L) 12.2 (5.3) 13.0 (6.0)
Fasting glucose (mg/dL) 87.4 (9.5) 89.1 (8.9)
HOMA-IR (mass units) 2.7 (1.4) 2.9 (1.5)
Elevated metabolic risk, No. (%) 26/86 (24) 23/86 (28)
Fasting triglycerides (mg/dL) 79.3 (37.3) 88.1 (47.9)
FMD (%) 7.1 (5.2) 7.0 (4.7)
NMD (%) 28.1 (9.9) 28.1 (9.2)
Baseline Measures Obtained during Stress Testing (averaged across all testing phases)
SBP (mmHg) 127.7 (20.7) 125.9 (19.6)
DBP (mmHg) 77.7 (10.5) 77.4 (10.7)
Heart rate (bpm) 74.7 (13.6) 74.7 (15.3)
Cardiac output (l/min) 7.0 (2.0) 6.8 (2.1)
Total peripheral resistance (mmHg*min*mL-1) 1140.2 (363.4) 1193.8 (372.1)
Cortisol (μg/dL) 7.6 (4.4) 7.6 (4.5)
ACTH (pg/mL) 65.3 (24.1) 68.8 (33.0)
Epinephrine (pg/mL) 54.2 (79.0) 61.8 (58.3)
Norepinephrine (pg/mL) 441.7 (171.4) 424.4 (147.7)
IL-6 (pg/mL) 1.4 (0.9) 1.3 (0.5)
Baroreceptor sensitivity (msec/mmHg) 5.2 (2.6) 5.2 (2.8)

Abbreviations: ACTH, adenocorticotropic hormone; DBP, diastolic blood pressure; FMD, flow-mediated dilation; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment of insulin resistance; IL-6, interleukin-6; LDL, low-density lipoprotein; NMD, nitroglycerine-mediated dilatation; SBP, systolic blood pressure.

a6 = some college (including completion of junior college); 7 = graduated from 4-year college.

b8 = $50 000 to $79 999; 9 = $80 000 to $99 999.